MAINTENANCE NOTIFICATION: There is a scheduled maintenance that will result in intermittent service interruption between 2pm and 5pm EST on Friday, April 3rd 2020
Menu
Search
Home > Courses > Update on Immunization Recommendations for Adolescents and Adults With and At-risk for HIV Disease

Update on Immunization Recommendations for Adolescents and Adults With and At-risk for HIV Disease

Update on Immunization Recommendations for Adolescents and Adults With and At-risk for HIV Disease
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 11/12/2019
Termination Date: 11/11/2022
Review Date: 2/7/2020
Presenter
  • Jane R. Zucker, MD, MSc, FIDSA
    Assistant Commissioner
    NYC Department of Health and Mental Hygiene
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Appreciate the epidemiology of vaccine-preventable infections in NYC, and the role that immunizations play in reducing their impact.
  2. Know the current recommendations for vaccines in at-risk adolescent and adult HIV-positive patients and PrEP candidates, including recent updates to meningococcal, hepatitis A, HPV and pneumococcal vaccine recommendations.
  3. Describe evidence-based strategies for increasing practice-level vaccination coverage rates.
Presenter Bio
Jane Zucker, MD, MSc, FIDSA
Jane R. Zucker has served as the Assistant Commissioner for the Bureau of Immunization at the New York City Department of Health and Mental Hygiene since August 2005. She is responsible for policy development, program management and integrity of the NYC Immunization Program. Under her leadership, vaccination coverage for routinely recommended vaccines, including influenza, have continued to increase among young children, adolescents and adults, while racial disparities have decreased. Further, she has established a strong Adult Immunization program that works to increase vaccination coverage of all recommended vaccines through implementation of evidenced-based strategies.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on November 12, 2019 and will terminate November 11, 2022.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Jane Zucker, MD (Presenter) had no relevant financial relationships to disclose. Dr. Zucker submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules